Novo Nordisk A/S News Headlines

NVO 
$45.91
*  
unch
unch
Get NVO Alerts
*Delayed - data as of Jul. 28, 2014  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?
3/28/2013 5:43:00 AM - Seeking Alpha

Sanofi Reports Lemtrada Data - Analyst Blog
3/27/2013 4:25:06 PM - Zacks.com

Good News for Roche - Analyst Blog
3/27/2013 9:28:12 AM - Zacks.com

FDA Panel Favors Abbott's MitraClip - Analyst Blog
3/25/2013 6:26:53 PM - Zacks.com

CHMP in Favor of Sanofi's Aubagio - Analyst Blog
3/25/2013 5:30:47 PM - Zacks.com

Lilly, Boehringer Ingelheim Start Diabetes Study - Analyst Blog
3/25/2013 5:29:14 PM - Zacks.com

Positive Data on Novo Nordisk Candidate - Analyst Blog
3/25/2013 4:27:50 PM - Zacks.com

Painless Play To Fatten Up Your Portfolio: Buy Arena
3/25/2013 1:28:00 PM - Seeking Alpha

Positive Data on Novartis' Gilenya - Analyst Blog
3/25/2013 12:27:32 PM - Zacks.com

Novartis' Jetrea Gets EU Approval - Analyst Blog
3/22/2013 12:24:05 PM - Zacks.com

AstraZeneca/Moderna Ink Deal - Analyst Blog
3/22/2013 12:22:33 PM - Zacks.com

Label Expansion for Roche's Pegasys - Analyst Blog
3/21/2013 6:24:43 PM - Zacks.com

Brazil Approves Pfizer-Protalix Gaucher Drug - Analyst Blog
3/21/2013 10:33:19 AM - Zacks.com

Sanofi/MACK Candidate Progresses - Analyst Blog
3/20/2013 4:29:05 PM - Zacks.com

Data on Novo Nordisk's VIctoza - Analyst Blog
3/20/2013 1:49:35 PM - Zacks.com

Data on Eli Lilly's Cialis - Analyst Blog
3/19/2013 6:47:37 PM - Zacks.com

AstraZeneca to Revamp R&D Structure - Analyst Blog
3/19/2013 5:47:17 PM - Zacks.com

Merck-Luminex' Alzheimer's Collaboration - Analyst Blog
3/19/2013 4:47:42 PM - Zacks.com

Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 21, 2013
3/19/2013 9:00:04 AM - NASDAQ.com News

Merck to Continue IMPROVE-IT - Analyst Blog
3/18/2013 5:48:27 PM - Zacks.com

AbbVie-Receptos Collaborate - Analyst Blog
3/18/2013 4:45:24 PM - Zacks.com

Dividend Contenders: 18 Increases Expected By The End Of May
3/18/2013 5:12:00 AM - Seeking Alpha

Data on Abbott's MitraClip - Analyst Blog
3/15/2013 12:46:30 PM - Zacks.com

Shire Buys Premacure - Analyst Blog
3/14/2013 6:49:15 PM - Zacks.com

Longer Lasting Drugs Make For Longer Lasting Profits
3/14/2013 4:56:00 PM - Seeking Alpha